$23.32M Market Cap.
DRCT Market Cap. (MRY)
DRCT Shares Outstanding (MRY)
DRCT Assets (MRY)
Total Assets
$26.01M
Total Liabilities
$45.74M
Total Investments
$0
DRCT Income (MRY)
Revenue
$62.29M
Net Income
-$6.24M
Operating Expense
$30.62M
DRCT Cash Flow (MRY)
CF Operations
-$8.65M
CF Investing
-$17.00K
CF Financing
$4.99M
DRCT Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | - | 0% | 0% | - |
2020 | $0 | - | - | 0% | - |
DRCT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $26,006,000 (-63.20%) | $70,672,000 (21.58%) | $58,126,039 (61.46%) | $35,999,933 (17.28%) |
Assets Current | $8,535,000 (-80.19%) | $43,082,000 (37.71%) | $31,284,889 (127.01%) | $13,781,059 (111.54%) |
Assets Non-Current | $17,471,000 (-36.68%) | $27,590,000 (2.79%) | $26,841,150 (20.80%) | $22,218,874 (-8.11%) |
Goodwill & Intangible Assets | $16,250,000 (-10.73%) | $18,204,000 (-9.69%) | $20,157,395 (-8.84%) | $22,111,214 (-8.12%) |
Shareholders Equity | -$4,988,000 (-1018.60%) | $543,000 (-88.18%) | $4,595,282 (1325.88%) | -$374,856 (-115.83%) |
Property Plant & Equipment Net | $1,173,000 (-15.43%) | $1,387,000 (-5.77%) | $1,471,992 (0%) | $0 (0%) |
Cash & Equivalents | $1,445,000 (-71.76%) | $5,116,000 (26.40%) | $4,047,453 (-13.60%) | $4,684,431 (190.60%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $507,000 (33.07%) | $381,000 (-30.31%) | $546,710 (-59.45%) | $1,348,093 (336.73%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $4,973,000 (-87.23%) | $38,944,000 (47.77%) | $26,354,114 (234.82%) | $7,871,181 (68.21%) |
Trade & Non-Trade Payables | $7,657,000 (-77.43%) | $33,926,000 (77.22%) | $19,143,737 (182.32%) | $6,780,816 (85.79%) |
Accumulated Retained Earnings (Deficit) | -$8,774,000 (-245.71%) | -$2,538,000 (30.34%) | -$3,643,261 (21.97%) | -$4,669,097 (-142.43%) |
Tax Assets | $0 (0%) | $6,132,000 (18.73%) | $5,164,776 (0%) | $0 (0%) |
Tax Liabilities | $41,000 (-99.22%) | $5,276,000 (17.07%) | $4,506,628 (0%) | $0 (0%) |
Total Debt | $36,274,000 (17.18%) | $30,955,000 (26.06%) | $24,555,918 (18.37%) | $20,745,411 (59.73%) |
Debt Current | $3,888,000 (142.39%) | $1,604,000 (114.73%) | $746,989 (35.82%) | $550,000 (-54.42%) |
Debt Non-Current | $32,386,000 (10.34%) | $29,351,000 (23.28%) | $23,808,929 (17.89%) | $20,195,411 (71.43%) |
Total Liabilities | $45,736,000 (-38.49%) | $74,354,000 (38.90%) | $53,530,757 (47.16%) | $36,374,789 (28.41%) |
Liabilities Current | $13,350,000 (-66.46%) | $39,802,000 (55.65%) | $25,572,209 (162.99%) | $9,723,816 (46.61%) |
Liabilities Non-Current | $32,386,000 (-6.27%) | $34,552,000 (23.58%) | $27,958,548 (4.91%) | $26,650,973 (22.85%) |
DRCT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $62,288,000 (-60.35%) | $157,110,000 (75.82%) | $89,359,733 (134.31%) | $38,136,862 (205.64%) |
Cost of Revenue | $44,897,000 (-62.44%) | $119,536,000 (99.10%) | $60,037,657 (204.64%) | $19,707,737 (169.78%) |
Selling General & Administrative Expense | $30,624,000 (-0.99%) | $30,929,000 (44.91%) | $21,343,137 (51.97%) | $14,044,525 (171.00%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $30,624,000 (-22.98%) | $39,759,000 (86.28%) | $21,343,137 (51.97%) | $14,044,525 (133.42%) |
Interest Expense | $5,410,000 (23.57%) | $4,378,000 (35.52%) | $3,230,612 (1.46%) | $3,184,029 (268.07%) |
Income Tax Expense | $6,132,000 (979.58%) | $568,000 (73.91%) | $326,597 (414.12%) | $63,526 (423.97%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$19,907,000 (-190.87%) | -$6,844,000 (-264.26%) | $4,166,603 (376.47%) | -$1,507,097 (-65.95%) |
Net Income to Non-Controlling Interests | -$13,671,000 (-194.00%) | -$4,650,000 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$6,236,000 (-184.23%) | -$2,194,000 (-152.66%) | $4,166,603 (376.47%) | -$1,507,097 (-65.95%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$6,236,000 (-184.23%) | -$2,194,000 (-152.66%) | $4,166,603 (376.47%) | -$1,507,097 (-65.95%) |
Weighted Average Shares | $3,758,000 (25.77%) | $2,988,000 (-76.36%) | $12,637,551 (36871.36%) | $34,182 (14.11%) |
Weighted Average Shares Diluted | $3,758,000 (25.77%) | $2,988,000 (-76.36%) | $12,637,551 (36871.36%) | $34,182 (14.11%) |
Earning Before Interest & Taxes (EBIT) | $5,306,000 (92.81%) | $2,752,000 (-64.37%) | $7,723,812 (343.78%) | $1,740,458 (5712.39%) |
Gross Profit | $17,391,000 (-53.72%) | $37,574,000 (28.14%) | $29,322,076 (59.11%) | $18,429,125 (256.30%) |
Operating Income | -$13,233,000 (-505.63%) | -$2,185,000 (-127.38%) | $7,978,939 (81.98%) | $4,384,600 (619.16%) |
DRCT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$17,000 (90.45%) | -$178,000 (74.13%) | -$687,957 (0%) | $0 (0%) |
Net Cash Flow from Financing | $4,994,000 (480.93%) | -$1,311,000 (36.90%) | -$2,077,687 (-206.12%) | -$678,718 (-105.52%) |
Net Cash Flow from Operations | -$8,648,000 (-438.08%) | $2,558,000 (20.17%) | $2,128,666 (-43.25%) | $3,751,151 (752.91%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,671,000 (-443.41%) | $1,069,000 (267.82%) | -$636,978 (-120.73%) | $3,072,433 (321.05%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$17,000 (90.45%) | -$178,000 (74.13%) | -$687,957 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $4,327,000 (-17.78%) | $5,263,000 (90.80%) | $2,758,455 (-32.01%) | $4,057,331 (-66.87%) |
Issuance (Purchase) of Equity Shares | $1,953,000 (157.63%) | -$3,389,000 (-185.43%) | $3,967,043 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | -$1,692,434 (-36.92%) | -$1,236,049 (-951.88%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $1,552,000 (119.83%) | $706,000 (359.10%) | $153,778 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $2,385,000 (0.59%) | $2,371,000 (11.59%) | $2,124,743 (8.75%) | $1,953,818 (300.00%) |
DRCT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 27.90% (16.74%) | 23.90% (-27.13%) | 32.80% (-32.09%) | 48.30% (16.39%) |
Profit Margin | -10.00% (-614.29%) | -1.40% (-129.79%) | 4.70% (217.50%) | -4.00% (45.21%) |
EBITDA Margin | 12.30% (272.73%) | 3.30% (-70.00%) | 11.00% (13.40%) | 9.70% (162.16%) |
Return on Average Equity (ROAE) | 297.40% (585.15%) | -61.30% (-159.28%) | 103.40% (168.39%) | -151.20% (8.64%) |
Return on Average Assets (ROAA) | -15.70% (-390.63%) | -3.20% (-137.21%) | 8.60% (291.11%) | -4.50% (13.46%) |
Return on Sales (ROS) | 8.50% (372.22%) | 1.80% (-79.07%) | 8.60% (86.96%) | 4.60% (2400.00%) |
Return on Invested Capital (ROIC) | 16.10% (93.98%) | 8.30% (-72.61%) | 30.30% (175.45%) | 11.00% (1671.43%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -0.96 (95.30%) | -20.38 (-377.41%) | 7.35 | - |
Price to Sales Ratio (P/S) | 0.1 (-66.08%) | 0.28 (-17.49%) | 0.34 | - |
Price to Book Ratio (P/B) | -4.68 (-101.20%) | 391.06 (4997.20%) | 7.67 | - |
Debt to Equity Ratio (D/E) | -9.17 (-106.70%) | 136.93 (1075.48%) | 11.65 (112.00%) | -97.04 (-911.28%) |
Earnings Per Share (EPS) | -1.66 (-127.40%) | -0.73 (-321.21%) | 0.33 (100.75%) | -44.09 (-45.42%) |
Sales Per Share (SPS) | 16.57 (-68.48%) | 52.58 (643.60%) | 7.07 (-99.37%) | 1,115.7 (167.84%) |
Free Cash Flow Per Share (FCFPS) | -2.31 (-389.34%) | 0.8 (599.12%) | 0.11 (-99.90%) | 109.74 (672.16%) |
Book Value Per Share (BVPS) | -1.33 (-829.12%) | 0.18 (-50.00%) | 0.36 (103.32%) | -10.97 (-113.87%) |
Tangible Assets Book Value Per Share (TABVPS) | 2.6 (-85.22%) | 17.56 (484.55%) | 3 (-99.26%) | 406.32 (83.56%) |
Enterprise Value Over EBIT (EV/EBIT) | 11 (-86.90%) | 84 (1100.00%) | 7 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | 7.42 (-83.56%) | 45.14 (741.20%) | 5.37 | - |
Asset Turnover | 1.57 (-31.77%) | 2.3 (24.74%) | 1.85 (61.45%) | 1.14 (60.00%) |
Current Ratio | 0.64 (-40.94%) | 1.08 (-11.53%) | 1.22 (-13.69%) | 1.42 (44.30%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$8,665,000 (-464.08%) | $2,380,000 (65.20%) | $1,440,709 (-61.59%) | $3,751,151 (752.91%) |
Enterprise Value (EV) | $57,066,963 (-75.32%) | $231,249,368 (337.54%) | $52,852,149 | - |
Earnings Before Tax (EBT) | -$104,000 (93.60%) | -$1,626,000 (-136.19%) | $4,493,200 (411.26%) | -$1,443,571 (-61.10%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $7,691,000 (50.13%) | $5,123,000 (-47.98%) | $9,848,555 (166.59%) | $3,694,276 (707.59%) |
Invested Capital | $31,235,000 (-18.88%) | $38,505,000 (17.02%) | $32,904,900 (62.69%) | $20,225,883 (77.83%) |
Working Capital | -$4,815,000 (-246.80%) | $3,280,000 (-42.58%) | $5,712,680 (40.80%) | $4,057,243 (3544.79%) |
Tangible Asset Value | $9,756,000 (-81.41%) | $52,468,000 (38.19%) | $37,968,644 (173.38%) | $13,888,719 (109.47%) |
Market Capitalization | $23,321,963 (-89.02%) | $212,343,924 (502.30%) | $35,255,533 | - |
Average Equity | -$2,096,500 (-158.53%) | $3,581,900 (-11.11%) | $4,029,601 (304.29%) | $996,717 (81.64%) |
Average Assets | $39,635,750 (-41.87%) | $68,188,776 (40.97%) | $48,371,314 (45.05%) | $33,347,704 (91.00%) |
Invested Capital Average | $32,990,750 (-0.87%) | $33,281,794 (30.77%) | $25,451,247 (61.09%) | $15,799,664 (255.00%) |
Shares | 14,667,901 (2.79%) | 14,270,425 (-1.84%) | 14,538,364 (2.90%) | 14,128,000 (0.00%) |
